Welcome to LookChem.com Sign In|Join Free

CAS

  • or

22027-53-8

Post Buying Request

22027-53-8 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

22027-53-8 Usage

Description

METHYL (4-CHLOROBENZOYL)ACETATE is an organic compound that serves as a key intermediate in the synthesis of various pharmaceuticals, agrochemicals, and other specialty chemicals. It is characterized by its molecular structure, which includes a methyl ester group and a 4-chlorobenzoyl group, providing it with unique reactivity and properties that make it valuable in chemical synthesis.

Uses

Used in Pharmaceutical Industry:
METHYL (4-CHLOROBENZOYL)ACETATE is used as a reactant for the synthesis of various pharmaceutical compounds. Its unique reactivity allows for the formation of complex molecules with potential therapeutic applications.
Used in Agrochemical Industry:
METHYL (4-CHLOROBENZOYL)ACETATE is used as a building block in the development of agrochemicals, such as pesticides and herbicides. Its chemical properties enable the creation of effective compounds for crop protection and management.
Used in Specialty Chemicals:
METHYL (4-CHLOROBENZOYL)ACETATE is used as an intermediate in the production of specialty chemicals, which find applications in various industries, including plastics, coatings, and dyes.
Reactant involved in:
METHYL (4-CHLOROBENZOYL)ACETATE is involved in several chemical reactions, including:
1. Oxidative coupling with aminopyridines: This reaction allows for the formation of novel heterocyclic compounds with potential applications in various fields.
2. Enantioselective hydrogenation of unprotected β-enamine esters: This reaction enables the selective synthesis of chiral compounds, which are important in the pharmaceutical industry.
3. Intramolecular cyclization: This reaction is used to form cyclic compounds, which can have various applications depending on their specific structures.
4. Oxidative alkylation of benzylic C-H bonds: This reaction allows for the functionalization of benzylic positions, leading to the formation of new compounds with different properties and applications.
5. Tandem oxidative coupling and annulation of phenols: This reaction enables the formation of complex polycyclic structures, which can be used in the synthesis of natural products and other biologically active compounds.

Check Digit Verification of cas no

The CAS Registry Mumber 22027-53-8 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 2,2,0,2 and 7 respectively; the second part has 2 digits, 5 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 22027-53:
(7*2)+(6*2)+(5*0)+(4*2)+(3*7)+(2*5)+(1*3)=68
68 % 10 = 8
So 22027-53-8 is a valid CAS Registry Number.
InChI:InChI=1/C10H9ClO3/c1-14-10(13)6-9(12)7-2-4-8(11)5-3-7/h2-5H,6H2,1H3

22027-53-8SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name Methyl 3-(4-chlorophenyl)-3-oxopropanoate

1.2 Other means of identification

Product number -
Other names (p-Chlorobenzoyl)acetic acid methyl ester Methyl 3-(4-chlorophenyl)-3-oxopropionate

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:22027-53-8 SDS

22027-53-8Relevant articles and documents

Discovery of 7-alkyloxy- [1,2,4] triazolo[1,5-a] pyrimidine derivatives as selective positive modulators of GABAA1 and GABAA4 receptors with potent antiepileptic activity

Wu, Jun,Hou, Zhipeng,Wang, Yan,Chen, Liping,Lian, Chengxi,Meng, Qingfei,Zhang, Chaoying,Li, Xiufen,Huang, Longjiang,Yu, Haibo

, (2021/12/20)

A series of 7-alkoxy - [1,2,4] triazolo [1, 5-a] pyrimidine derivatives were designed and synthesized. Maximal electroshock (MES) and pentylenetetrazole (PTZ) tests were utilized to access their anticonvulsant activity. Most of the series of compounds exhibited significant anti-seizure effects. Further studies demonstrated that the anticonvulsant activity of these compounds mainly depended on their allosteric potentiation of GABAA receptors. Among them, compound 10c was picked for the mechanism study due to its potent activity. The compound is more sensitive to subunit configurations of synaptic α1β2γ2 and extrasynaptic α4β3δ GABAA receptors, but there were no effects on NMDA receptors and Nav1.2 sodium channels. Meanwhile, 10c acted on the sites of GABAA receptors distinct from commonly used anticonvulsants benzodiazepines and barbiturates. Furthermore, studies from native neurons demonstrated that compound 10c also potentiated the activity of native GABAA receptors and reduced action potential firings in cultured cortical neurons. Such structural compounds may lay a foundation for further designing novel antiepileptic molecules.

Enantioselective decarboxylative Mannich reaction of β-keto acids withC-alkynylN-BocN,O-acetals: access to chiral β-keto propargylamines

Chen, Li-Jun,Li, Wei,Shen, Bao-Chun,Sun, Zhong-Wen,Xie, Hui-Ding,Zhang, Cong-Cong

supporting information, p. 8607 - 8612 (2021/10/20)

The chiral keto-substituted propargylamines are an essential class of multifunctional compounds in the field of organic and pharmaceutical synthesis and have attracted considerable attention, but the related synthetic approaches remain limited. Therefore, a concise and efficient method for the enantioselective synthesis of β-keto propargylaminesviachiral phosphoric acid-catalyzed asymmetric Mannich reaction between β-keto acids andC-alkynylN-BocN,O-acetals as easily availableC-alkynyl imine precursors has been demonstrated here, affording a broad scope of β-ketoN-Boc-propargylamines in high yields (up to 97%) with generally high enantioselectivities (up to 97?:?3 er).

AMINOPYRIMIDINE DERIVATIVES AND THEIR USE AS ARYL HYDROCARBON RECEPTOR MODULATORS

-

Paragraph 1368; 1377-1380, (2021/10/02)

The present invention relates to novel compounds effective as modulators Aryl hydrocarbon receptor (AhR), pharmaceutical composition comprising the compounds for the modulation of AhR, or prevention or treatment of a disease, disorder, or condition associ

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 22027-53-8